173 related articles for article (PubMed ID: 33006574)
1. Crystallization and structure of ebselen bound to Cys141 of human inositol monophosphatase.
Fenn GD; Waller-Evans H; Atack JR; Bax BD
Acta Crystallogr F Struct Biol Commun; 2020 Oct; 76(Pt 10):469-476. PubMed ID: 33006574
[TBL] [Abstract][Full Text] [Related]
2. Effects of the putative lithium mimetic ebselen on pilocarpine-induced neural activity.
Singh N; Serres F; Toker L; Sade Y; Blackburn V; Batra AS; Saiardi A; Agam G; Belmaker RH; Sharp T; Vasudevan SR; Churchill GC
Eur J Pharmacol; 2020 Sep; 883():173377. PubMed ID: 32687920
[TBL] [Abstract][Full Text] [Related]
3. Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla.
Masaki C; Sharpley AL; Godlewska BR; Berrington A; Hashimoto T; Singh N; Vasudevan SR; Emir UE; Churchill GC; Cowen PJ
Psychopharmacology (Berl); 2016 Mar; 233(6):1097-104. PubMed ID: 26758281
[TBL] [Abstract][Full Text] [Related]
4. Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans.
Singh N; Sharpley AL; Emir UE; Masaki C; Herzallah MM; Gluck MA; Sharp T; Harmer CJ; Vasudevan SR; Cowen PJ; Churchill GC
Neuropsychopharmacology; 2016 Jun; 41(7):1768-78. PubMed ID: 26593266
[TBL] [Abstract][Full Text] [Related]
5. Ebselen has lithium-like effects on central 5-HT
Antoniadou I; Kouskou M; Arsiwala T; Singh N; Vasudevan SR; Fowler T; Cadirci E; Churchill GC; Sharp T
Br J Pharmacol; 2018 Jul; 175(13):2599-2610. PubMed ID: 29488218
[TBL] [Abstract][Full Text] [Related]
6. A phase 2a randomised, double-blind, placebo-controlled, parallel-group, add-on clinical trial of ebselen (SPI-1005) as a novel treatment for mania or hypomania.
Sharpley AL; Williams C; Holder AA; Godlewska BR; Singh N; Shanyinde M; MacDonald O; Cowen PJ
Psychopharmacology (Berl); 2020 Dec; 237(12):3773-3782. PubMed ID: 32909076
[TBL] [Abstract][Full Text] [Related]
7. The putative lithium-mimetic ebselen reduces impulsivity in rodent models.
Barkus C; Ferland JN; Adams WK; Churchill GC; Cowen PJ; Bannerman DM; Rogers RD; Winstanley CA; Sharp T
J Psychopharmacol; 2018 Sep; 32(9):1018-1026. PubMed ID: 29986609
[TBL] [Abstract][Full Text] [Related]
8. A safe lithium mimetic for bipolar disorder.
Singh N; Halliday AC; Thomas JM; Kuznetsova OV; Baldwin R; Woon EC; Aley PK; Antoniadou I; Sharp T; Vasudevan SR; Churchill GC
Nat Commun; 2013; 4():1332. PubMed ID: 23299882
[TBL] [Abstract][Full Text] [Related]
9. Structural and biochemical analysis of human inositol monophosphatase-1 inhibition by ebselen.
Abuhammad A; Laurieri N; Rice A; Lowe ED; Singh N; Naser SM; Ratrout SS; Churchill GC
J Biomol Struct Dyn; 2023; 41(23):14036-14048. PubMed ID: 36762717
[TBL] [Abstract][Full Text] [Related]
10. Co-crystallization of human inositol monophosphatase with the lithium mimetic L-690,330.
Kraft L; Roe SM; Gill R; Atack JR
Acta Crystallogr D Struct Biol; 2018 Oct; 74(Pt 10):973-978. PubMed ID: 30289407
[TBL] [Abstract][Full Text] [Related]
11. Cysteine Modification by Ebselen Reduces the Stability and Cellular Levels of 14-3-3 Proteins.
Waløen K; Jung-Kc K; Vecchia ED; Pandey S; Gasparik N; Døskeland A; Patil S; Kleppe R; Hritz J; Norton WHJ; Martinez A; Haavik J
Mol Pharmacol; 2021 Aug; 100(2):155-169. PubMed ID: 34031189
[TBL] [Abstract][Full Text] [Related]
12. Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing.
Masaki C; Sharpley AL; Cooper CM; Godlewska BR; Singh N; Vasudevan SR; Harmer CJ; Churchill GC; Sharp T; Rogers RD; Cowen PJ
Psychopharmacology (Berl); 2016 Jul; 233(14):2655-61. PubMed ID: 27256357
[TBL] [Abstract][Full Text] [Related]
13. In vitro evaluation of glutathione peroxidase (GPx)-like activity and antioxidant properties of some Ebselen analogues.
Mouithys-Mickalad Mareque A; Faez JM; Chistiaens L; Kohnen S; Deby C; Hoebeke M; Lamy M; Deby-Dupont G
Redox Rep; 2004; 9(2):81-7. PubMed ID: 15231062
[TBL] [Abstract][Full Text] [Related]
14. Ebselen-binding equilibria between plasma and target proteins.
Ullrich V; Weber P; Meisch F; von Appen F
Biochem Pharmacol; 1996 Jul; 52(1):15-9. PubMed ID: 8678900
[TBL] [Abstract][Full Text] [Related]
15. Ebselen.
Sies H
Methods Enzymol; 1995; 252():341-2. PubMed ID: 7476371
[No Abstract] [Full Text] [Related]
16. Molecular actions of ebselen--an antiinflammatory antioxidant.
Schewe T
Gen Pharmacol; 1995 Oct; 26(6):1153-69. PubMed ID: 7590103
[TBL] [Abstract][Full Text] [Related]
17. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.
Goins CM; Dajnowicz S; Thanna S; Sucheck SJ; Parks JM; Ronning DR
ACS Infect Dis; 2017 May; 3(5):378-387. PubMed ID: 28285521
[TBL] [Abstract][Full Text] [Related]
18. The neuroprotective agent ebselen modifies NMDA receptor function via the redox modulatory site.
Herin GA; Du S; Aizenman E
J Neurochem; 2001 Sep; 78(6):1307-14. PubMed ID: 11579139
[TBL] [Abstract][Full Text] [Related]
19. Effects of ebselen addition on emotional processing and brain neurochemistry in depressed patients unresponsive to antidepressant medication.
Ramli FF; Singh N; Emir UE; Villa LM; Waters S; Harmer CJ; Cowen PJ; Godlewska BR
Transl Psychiatry; 2024 May; 14(1):200. PubMed ID: 38714646
[TBL] [Abstract][Full Text] [Related]
20. Interaction of albumin-bound ebselen with rat liver glutathione S-transferase and microsomal proteins.
Nikawa T; Schuch G; Wagner G; Sies H
Biochem Mol Biol Int; 1994 Feb; 32(2):291-8. PubMed ID: 8019434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
